Activated solubility neuregulin hypotype through post translational modification

Activated solubility neuregulin hypotype through post translational modification

  • CN 101,903,036 A
  • Filed: 11/17/2008
  • Published: 12/01/2010
  • Est. Priority Date: 11/16/2007
  • Status: Active Application
First Claim
Patent Images

1. Chong Zu solubility neuregulin-1 NRG-1 Neu Differentiation Factor NDF glial growth factors GGF hypotype is used to prepare the purposes of the medicine for the treatment of nervous system disease.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×